myeloma

(redirected from myelomas)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to myelomas: multiple myeloma

my·e·lo·ma

 (mī′ə-lō′mə)
n. pl. my·e·lo·mas or my·e·lo·ma·ta (-mə-tə)
A malignant tumor formed by the cells of the bone marrow.

my′e·lo′ma·toid′ (-toid′) adj.

myeloma

(ˌmaɪɪˈləʊmə)
n, pl -mas or -mata (-mətə)
(Pathology) a usually malignant tumour of the bone marrow or composed of cells normally found in bone marrow
ˌmyeˈlomaˌtoid adj

my•e•lo•ma

(ˌmaɪ əˈloʊ mə)

n., pl. -mas, -ma•ta (-mə tə)
a tumor of plasma cells, arising in bone marrow and often occurring at multiple sites.
[1855–60]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.myeloma - a tumor of the bone marrow (usually malignant) composed of cells normally found in bone marrow
malignant neoplasm, malignant tumor, metastatic tumor - a tumor that is malignant and tends to spread to other parts of the body
multiple myeloma - myeloma that develops in several places at the same time
Translations

my·e·lo·ma

n. mieloma.
1. cualquier tumor de la médula espinal u ósea;
2. tumor formado por el tipo de células que se encuentran en la médula ósea;
multiple ______ múltiple.

myeloma

n mieloma m; multiple — mieloma múltiple
References in periodicals archive ?
Depending on their site of development and clinical features, malignant tumors of monoclonal antibody-producing plasma cells are classified as either multiple myelomas, solitary plasmacytomas, or extramedullary plasmacytomas.
com/research/f01e93/understanding_leuk) has announced the addition of the "Understanding Leukemias, Lymphomas and Myelomas, Second Edition" book to their offering.
NeoRx Corporation (NASDAQ: NERX), a cancer therapeutics development company, today announced that William Bensinger, MD, Member, Fred Hutchinson Cancer Research Center, Seattle, will present results of phase I/II studies of STR(TM) (Skeletal Targeted Radiotherapy) in patients with multiple myeloma at the Workshop on Novel Therapeutic Approaches to Myeloma, International Congress on Hematological Malignancies: Focus on Leukemias, Lymphomas, and Myelomas, on March 12, 2004, in Whistler, BC.